Related Experiment Videos

Mycobacterium kansasii infections in patients positive for human immunodeficiency virus

J L Carpenter1, J M Parks

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8889.

Insights

Mycobacterium kansasii infections are rare in human immunodeficiency virus (HIV)-positive patients. While disseminated infections show poor treatment response, pulmonary cases may benefit from therapy.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Immunology

Background:

  • Review of Mycobacterium kansasii infections in human immunodeficiency virus (HIV)-positive patients.
  • Emphasis on the rarity of M. kansasii infections in this population.

Observation:

  • M. kansasii infections in HIV-positive patients present as either pulmonary or disseminated disease.
  • Limited therapeutic response is observed in disseminated M. kansasii infections.

Findings:

  • Patients with pulmonary M. kansasii infections show potential for therapeutic response.
  • Disseminated M. kansasii infections in HIV-positive individuals often lack a significant therapeutic response.

Implications:

  • Highlights the need for further research into diagnostic and therapeutic strategies for M. kansasii in HIV-positive patients.
  • Suggests differential treatment approaches based on infection classification (pulmonary vs. disseminated).
  • Underscores the importance of considering M. kansasii in the differential diagnosis of pulmonary infections in HIV-positive individuals.

Related Concept Videos